← Back
$DVAX All transactions

DYNAVAX TECHNOLOGIES CORP

A

$ Value

$0

Shares

5,758

Price

$0

Filed

Jun 13

Insider

Name

Myers Scott Dunseth

Title

CIK

0001356256

Roles

Director

Transaction Details

Transaction Date

2025-06-11

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

31,204

Footnotes

These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company. | This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.

Filing Info

Accession No.

0001029142-25-000102

Form Type

4

Issuer CIK

0001029142

Myers Scott Dunseth's History

Date Ticker Type Value
2026-02-10 DVAX U
2026-02-10 DVAX D
2026-02-10 DVAX D
2026-02-10 DVAX D
2026-02-10 DVAX D
2026-02-10 DVAX D
2026-02-10 DVAX D
2025-08-22 DVAX $41K
2025-06-17 ZNTL A $0
2025-06-11 DVAX A $0

Other Insiders at DVAX (90d)

Insider Bought Sold Last
KISNER DANIEL L 2026-02-10
SILVERNAIL LAUREN P 2026-02-10
CANO FRANCIS 2026-02-10
Myers Scott Dunseth 2026-02-10
Slebir John L
SVP General Counsel
2026-02-10
Novack David F
President & COO
2026-02-10
Spencer Ryan
CEO and Director
2026-02-10
MacDonald Kelly
SVP and CFO
2026-02-10
Sun Elaine D 2026-02-10
MacGregor Brent 2026-02-10
Deep Track Biotechnology Master Fund, Ltd. 2026-02-10
Emini Emilio 2026-02-10
Metzinger Joseph Anthony
VP, Chief Accounting Officer
2026-02-10